Phase I Study of GN-037 Cream for Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
In this Phase I study, three different doses (low, medium and high dose, on the basis of surface area applied) of GN-037 cream (12 volunteers in total) and placebo (6 volunteers in total) will be administered to healthy volunteers. In the active dose arm, 4 healthy volunteers will receive GN-037 cream and 2 healthy volunteers will receive placebo. Randomization in each dose arm will be 2:1.
Epistemonikos ID: 048ceb331130b5202141c53d6911228dce991c3b
First added on: May 13, 2024